GSK Investigational Site

Río Cuarto 5800

0 studies enrolling now · 2 studies all time

What they study most

Meningitis, Meningococcal, Respiratory Syncytial Virus

Studies at this site

• Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine — Completed
• A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age — Completed